Association of Antibodies to <i>Prevotella copri</i> in Anti–Cyclic Citrullinated <scp>Peptide‐Positive</scp> Individuals At Risk of Developing Rheumatoid Arthritis and in Patients With Early or Established Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Association of Antibodies to Prevotella copri in Anti–Cyclic Citrullinated Peptide‐Positive Individuals At Risk of Developing Rheumatoid Arthritis and in Patients With Early or Established Rheumatoid Arthritis

Published:2023-02-22 Issue:4 Volume:75 Page:507-516
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Seifert Jennifer A.¹^ORCID,Bemis Elizabeth A.¹,Ramsden Kristina²,Lowell Cassidy²,Polinski Kristen¹,Feser Marie¹,Fleischer Chelsie¹^ORCID,Demoruelle M. Kristen¹^ORCID,Buckner Jane³,Gregersen Peter K.⁴,Keating Richard M.⁵,Mikuls Ted R.⁶^ORCID,O'Dell James R.⁶,Weisman Michael H.⁷,Deane Kevin D.¹^ORCID,Norris Jill M.¹,Steere Allen C.²^ORCID,Holers V. Michael¹

Affiliation:

1. University of Colorado Denver

2. Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School Boston Massachusetts

3. Benaroya Research Institute at Virginia Mason Seattle Washington

4. Feinstein Institutes for Medical Research and North Shore‐Long Island Jewish Health System Manhasset New York

5. University of Chicago Illinois

6. University of Nebraska Medical Center and VA Nebraska‐Western Iowa Healthcare System Omaha Nebraska

7. Stanford University School of Medicine Palo Alto California

Funder

NIH

Mathers Foundation

Lucius N. Littauer Foundation